logo
episode-header-image
Oct 2024
2m 45s

U.S. Stocks End the Week Higher

The Wall Street Journal
About this episode

Plus: Netflix shares hit a record high following its most profitable quarter ever. And CVS Health fell after the healthcare giant replaced its CEO and warned on earnings. Plus, french fry producer Lamb Weston’s shares soar. Danny Lewis hosts.


Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Up next
Yesterday
Nasdaq Rises to New Record as President Trump Sends More Tariff Letters
Plus: Drugmaker Merck strikes a roughly $10 billion deal to buy Verona Pharma. The Justice Department’s criminal healthcare-fraud unit investigates UnitedHealth’s Medicare billing practices. And, shares in advertising conglomerate WPP tumble after it said clients were pulling bac ... Show More
2m 38s
Yesterday
Trump Administration Goes After Harvard’s Accreditation
Plus, Linda Yaccarino steps down as CEO of X after two years on the job. And U.S. measles cases hit a 33-year high. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 41s
Yesterday
Trump Losing Patience With Putin Over Ukraine
Plus: The U.S. seeks to ban China from buying American farmland. And a key architect of Apple’s supply chain will step down later this month. Luke Vargas hosts. Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 53s
Recommended Episodes
Oct 2024
What’s News in Markets: United Soars, CVS Warns, Netflix Shines
How did rivals help United take off? And what has investors worried about the health of CVS? Plus, why Netflix shares jumped. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Lea ... Show More
5m 27s
May 21
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica ... Show More
20m 12s
Apr 22
Markets Rebound After Monday’s Drop… And Netflix Streams Higher 4/22/25
Stocks ripping on Wall Street, as markets bounce back after Monday’s sell-off. The sectors seeing the biggest jumps, and how Tesla results are moving the stock. Plus Netflix shrugging off this year’s tariff concerns, jumping nearly 20% as the s&p 500 heads in the other direction. ... Show More
48m 31s
Apr 19
What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion
Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove ... Show More
5m 13s
Aug 2024
A Blip or a Trend? Making Sense of Monday’s Stock Selloff
A.M. Edition for August 6. U.S. stock futures rise and Japan’s Nikkei has climbs 10% after yesterday’s market freak-out. WSJ Heard on the Street columnist Jon Sindreu explains how Monday’s rout may have been exaggerated by trend chasers. Plus, WSJ tech reporter Sam Schechner look ... Show More
11m 38s
Apr 29
What’s News in Earnings: Defense Contractors Thrive in Uncertain World
Bonus Episode for April 29. Every U.S. manufacturer faces increased costs because of import tariffs and other countries’ countermeasures, but those making weapons have reason to be both worried and hopeful. WSJ Investing columnist Spencer Jakab discusses with WSJ reporter Sharon ... Show More
8m 52s
Oct 2021
Supply Chain Crunch Impact on Earnings, Intel Slumps, Snap Tumbles on "Apple Effect," the "Trump SPAC" Skyrockets -- and a New Record High for the S&P 500
Carl Quintanilla, Morgan Brennan and Mike Santoli focused on a barrage of earnings reports in which the supply chain crunch played a big role in quarterly results. Intel shares took a big hit after the chipmaker warned of lower profit margins and missed on quarterly revenue in wa ... Show More
43m 48s
Jan 2025
What’s News in Markets: Banking Boom, Macy’s Troubles, Drugmakers Slide
What’s driving big banks’ profit gains? And what was the result of the holiday season at Macy’s? Plus, what drove drops in some drugmakers’ shares? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Market ... Show More
6m 3s
Listen to millions of songs and podcasts on Anghami